IL-18 is required for the TH1-adaptation of TREG cells and the selective suppression of TH17 responses in acute and chronic infections

Mucosal Immunol. 2023 Aug;16(4):462-475. doi: 10.1016/j.mucimm.2023.05.004. Epub 2023 May 13.

Abstract

Interleukin (IL)-18, a member of the IL-1 family of alarmins, is abundantly released in the lungs following influenza A (IAV) infections yet its role in orchestrating the local adaptive immune response remains ill defined. Through genetic disruption of the IL-18 receptor, we demonstrate that IL-18 not only promotes pulmonary TH1 responses but also influences regulatory T cells (TREG) function in the infected lungs. As the response unfolds, TREG cells accumulating in the lungs express Helios, T-bet, CXCR3, and IL-18R1 and produce interferon γ in the presence of IL-12. During IAV, IL-18R1 is required for TREG cells to control TH17, but not TH1, responses and promote a return to lung homeostasis, revealing a novel mechanism of selective suppression. Moreover, this observation was not limited to the lungs, as skin-localized TREG cells require an IL-18 signal to specifically suppress IL-17A production by TH17 and γδ T cells in a model of chronic cutaneous Leishmania major infection. Overall, these results uncover how IL-18 orchestrates the tissue adaptation of TREG cells to selectively favor TH1 over TH17 responses during TH1-driven immune responses and provide a novel perspective into how IL-18 dictates the immune response during viral and parasitic infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interferon-gamma
  • Interleukin-12
  • Interleukin-18*
  • Persistent Infection*
  • T-Lymphocytes, Regulatory
  • Th1 Cells
  • Th17 Cells

Substances

  • Interleukin-18
  • Interferon-gamma
  • Interleukin-12

Grants and funding